dimanche 15 novembre 2026
RechercherExplore
Via News Knowledge File

Morgan Stanley & Co. LLC

organization80% conf.·synced Nov 15, 2026

Financial advisor to Avadel in the proposed transaction

60
sourced metrics
1113
relationships
20
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Market Cap
297994312862USD
Nov 13, 2026reference only
Price 52 Week Low
154.37USD
Nov 13, 2026reference only
Stock Return Ytd
4.8%
Nov 13, 2026reference only
Stock Price
190.65USD
Nov 13, 2026reference only
Price 52 Week High
228.55USD
Nov 13, 2026reference only
Shares Outstanding
1563043865.0shares
Oct 30, 2026reference only
Stockholders Equity
117109000000.0USD
Sep 30, 2026reference only
Eps
3.03USD_per_share
Sep 30, 2026reference only
Total Liabilities
1573707000000.0USD
Sep 30, 2026reference only
Net Income
4909000000.0USD
Sep 30, 2026reference only
Total Assets
1692027000000.0USD
Sep 30, 2026reference only
Cash
138669000000.0USD
Sep 30, 2026reference only
Operating Cash Flow
-7098000000.0USD
Mar 31, 2026reference only

Stated objectives

Morgan Stanley increasing focus on less capital market-dependent operations to aid growth and enhance capital distribution activities

source
stated

Achieve ROTCE in the low to mid-20s over time through synergies and capital deployment

source
target: low-to-mid-20s stated

New recommended portfolio allocation: 60% stocks, 20% fixed income, 20% gold

source
target: 60/20/20 stated

Path to over $10 trillion in client assets

source
target: 10 stated

Sustained 20%+ ROTCE through market cycles

source
target: 20 stated

Ability to generate 17.5% ROTCE in challenging environment with earnings below $8

source
target: 17.5 stated

Scale AI tools throughout the enterprise and client base

source
stated

Institutional trading wallet growth of 5-10% per annum

source
target: 5-10 stated

Recommend investors shift from 60/40 stocks/bonds to 60/20/20 stocks/fixed income/gold allocation

source
target: 60% stocks, 20% fixed income, 20% gold stated

S&P 500 to reach 7,500 by year-end 2026

source
target: 7500 by 2026-12-31 00:00:00stated

Relationship graph · 1113 connections

Covered by
491
Employs
274
rates
78
underwrites
46
Competes with
44
subsidiary of
34
Developed by
19
regulates
14

Where sources disagree

We surface conflicts between sources rather than hiding them.

value conflictunresolved

Two significantly different EPS values (10.21 vs 2.68 USD_per_share) are reported for Morgan Stanley on the same observation date (2025-12-31). Fact A specifies FY 2025, while Fact B's 'N/A' fiscal period is ambiguous. If both represent FY 2025 annual EPS, these values directly conflict. The magnitude of the difference (3.8x) is too large to attribute to rounding or minor calculation variations. The missing fiscal period in Fact B raises data quality concerns, but same-date observation + same attribute should reference the same period.

value conflictunresolved

The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.

value conflictunresolved

Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com